Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prospects for human mucosal vaccines.

J Mestecky1, J R McGhee

  • 1Department of Microbiology, University of Alabama, Birmingham 35294-10005.

Advances in Experimental Medicine and Biology
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chemokine-adjuvanted electroporated DNA vaccine induces substantial protection from simian immunodeficiency virus vaginal challenge.

Mucosal immunology·2015
Same author

Humoral immune response to keyhole limpet haemocyanin, the protein carrier in cancer vaccines.

Clinical & developmental immunology·2011
Same author

[Treatment of IgA nephropathy].

Vnitrni lekarstvi·2008
Same author

Role of aberrant glycosylation of IgA1 molecules in the pathogenesis of IgA nephropathy.

Kidney & blood pressure research·2008
Same author

Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels.

Kidney international·2007
Same author

[Immunoglobulin A and renal diseases].

Vnitrni lekarstvi·2006

Oral immunization effectively induces secretory IgA (S-IgA) antibodies and mucosal immunity. Novel antigen delivery systems enhance this response, offering advantages over systemic routes for preventing mucosal infections.

Area of Science:

  • Immunology
  • Microbiology
  • Vaccinology

Background:

  • Mucosal membranes are protected by secretory IgA (S-IgA) antibodies, crucial for preventing infections.
  • Systemic administration of IgA is ineffective for passive immunization due to poor entry into secretions.
  • Effective S-IgA responses can be boosted systemically only if prior mucosal exposure has occurred.

Purpose of the Study:

  • To review novel antigen delivery systems for stimulating S-IgA and mucosal immunity.
  • To highlight the advantages of oral immunization over systemic routes for inducing mucosal immunity.

Main Methods:

  • Review of literature on mucosal immunity and antigen delivery systems.
  • Discussion of IgA antibody induction via different immunization routes.

Related Experiment Videos

  • Exploration of novel delivery systems like engineered bacteria, liposomes, and microspheres.

    • Main Results:

    • Oral and inhalation immunization induce local and generalized S-IgA responses.
    • Antigen-sensitized cells disseminate from inductive sites to various mucosal tissues.
    • Novel delivery systems show promise for efficient antigen delivery to intestinal tissues.

    Conclusions:

    • Oral immunization offers significant advantages over systemic routes for inducing mucosal immunity.
    • Careful consideration of inductive sites and compartmentalization within the Common Mucosal Immune System is necessary.
    • Mucosal routes are more acceptable, simplify logistics, and allow simultaneous immunization of large populations.